Literature DB >> 9126095

Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer?

E T Fernandes1, C P Sundaram, R Long, M Soltani, C J Ercole.   

Abstract

OBJECTIVE: To evaluate the role of the Gleason score of needle biopsies of the prostate in predicting the final pathological staging of patients with carcinoma of the prostate treated by radical prostatectomy. PATIENTS AND METHODS: The records of 466 patients with carcinoma of the prostate treated by radical prostatectomy were reviewed, comparing the Gleason scores of the core-needle biopsies with the Gleason score and final pathological staging of the surgical specimens.
RESULTS: The biopsy grade was the same as that of the prostatectomy specimen in 54% of the patients. The most common discordance was the upgrading of well-differentiated tumours in 75% of the patients. When the biopsy grade was compared with the surgical pathological stage, 49% of low- and 82% of high-grade lesions in the biopsy had capsular penetration by tumour or locally advanced disease (Stage C and D1).
CONCLUSION: Well-differentiated tumours on the biopsy core are not predictive of organ-confined disease, but a poorly differentiated lesion is a good indicator of extracapsular extension of the cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9126095     DOI: 10.1046/j.1464-410x.1997.00126.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  13 in total

1.  Predictors of Gleason score upgrading in a large African-American population.

Authors:  Anup Vora; Tim Large; Jenny Aronica; Sherod Haynes; Andrew Harbin; Daniel Marchalik; Hanaa Nissim; John Lynch; Gaurav Bandi; Kevin McGeagh; Keith Kowalczyk; Reza Ghasemian; Krishnan Venkatesan; Mohan Verghese; Jonathan Hwang
Journal:  Int Urol Nephrol       Date:  2013-07-18       Impact factor: 2.370

2.  Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men.

Authors:  M Kongnyuy; M M Siddiqui; A K George; A Muthigi; A Sidana; M Maruf; B Turkbey; P L Choyke; B J Wood; P A Pinto
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-04-25       Impact factor: 5.554

3.  Detecting Prostate Cancer.

Authors:  Marko Brock; Christian von Bodman; Jüri Palisaar; Wolfgang Becker; Philipp Martin-Seidel; Joachim Noldus
Journal:  Dtsch Arztebl Int       Date:  2015-09-11       Impact factor: 5.594

4.  Improved multiparametric MRI discrimination between low-risk prostate cancer and benign tissues in a small cohort of 5α-reductase inhibitor treated individuals as compared with an untreated cohort.

Authors:  Olga Starobinets; John Kurhanewicz; Susan M Noworolski
Journal:  NMR Biomed       Date:  2017-02-06       Impact factor: 4.044

5.  The role of PSA density to predict a pathological tumour upgrade between needle biopsy and radical prostatectomy for low risk clinical prostate cancer in the modified Gleason system era.

Authors:  Stavros Sfoungaristos; Ioannis Katafigiotis; Petros Perimenis
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

6.  Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?

Authors:  Brian P Calio; Abhinav Sidana; Dordaneh Sugano; Sonia Gaur; Mahir Maruf; Amit L Jain; Maria J Merino; Peter L Choyke; Bradford J Wood; Peter A Pinto; Baris Turkbey
Journal:  J Urol       Date:  2018-01-20       Impact factor: 7.450

7.  Feasibility study of MR-guided transgluteal targeted in-bore biopsy for suspicious lesions of the prostate at 3 Tesla using a freehand approach.

Authors:  Frank Fischbach; Lukas Wien; Sascha Krueger; Bernhard Schnackenburg; Daniel Baumunk; Björn Friebe; Martin Schostak; Jens Ricke; Katharina Fischbach
Journal:  Eur Radiol       Date:  2018-01-17       Impact factor: 5.315

Review 8.  Diagnosis of prostate cancer via nanotechnological approach.

Authors:  Benedict J Kang; Minhong Jeun; Gun Hyuk Jang; Sang Hoon Song; In Gab Jeong; Choung-Soo Kim; Peter C Searson; Kwan Hyi Lee
Journal:  Int J Nanomedicine       Date:  2015-10-19

9.  Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification.

Authors:  Shane Mesko; Leonard Marks; Omar Ragab; Shyamal Patel; Daniel A Margolis; D Jeffrey Demanes; Mitchell Kamrava
Journal:  Am J Clin Oncol       Date:  2018-05       Impact factor: 2.787

10.  Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?

Authors:  Byung-Soo Jin; Seok-Hyun Kang; Duk-Yoon Kim; Hoon-Gyu Oh; Chun-Il Kim; Gi-Hak Moon; Tae-Gyun Kwon; Jae-Shin Park
Journal:  Korean J Urol       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.